ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.596
-0.03%
Brent Oil
83.645
0.06%
Bitcoin
66,408.68
0.20%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Invivyd Inc (IVVD)

  7. Invivyd Inc (IVVD) Noticias

IVVD Invivyd Inc

2.40
-0.05 (-2.04%)
17 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Invivyd Inc IVVD NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.05 -2.04% 2.40 17:32:52
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.40 2.37 2.45 2.40 2.45
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
16/5/202415:11EDGAR2Form 144 - Report of proposed sale of securities
13/5/202415:01GLOBEInvivyd to Participate at the H.C. Wainwright 2nd Annual..
09/5/202415:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/5/202415:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202415:08EDGAR2Form 8-K - Current report
09/5/202415:01GLOBEInvivyd Reports First Quarter 2024 Financial Results and..
07/5/202406:38EDGAR2Form 8-K - Current report
07/5/202406:30GLOBEInvivyd to Pursue Rapid Immunobridging Pathway to Potential..
02/5/202416:13GLOBEInvivyd to Host Conference Call Discussing First Quarter..
30/4/202406:30GLOBEInvivyd Announces $20 Million to $25 Million Improvement in..
15/4/202406:30GLOBEInvivyd Receives Healthcare Common Procedure Coding System..
12/4/202406:30GLOBEInvivyd Announces CEO Transition
04/4/202415:01GLOBEInvivyd Provides PEMGARDA™ Launch Update and Announces 2024..
28/3/202406:00GLOBEInvivyd Reports Full Year 2023 Financial Results and Recent..
22/3/202414:28GLOBEInvivyd Announces Interim Exploratory Data on VYD222 from..
22/3/202414:04GLOBEInvivyd Announces FDA Authorization for Emergency Use of..
12/2/202415:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202415:47EDGAR2Form S-3 - Registration statement under Securities Act of..
09/2/202415:01EDGAR2Form 8-K - Current report
05/2/202415:02GLOBEInvivyd to Participate at the Guggenheim Healthcare Talks..
26/1/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202415:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/1/202406:12EDGAR2Form 8-K - Current report
03/1/202406:06EDGAR2Form 8-K - Current report
03/1/202406:00GLOBEInvivyd Submits Request for Emergency Use Authorization..
22/12/202315:53EDGAR2Form 8-K - Current report
22/12/202315:51EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/12/202315:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202306:16EDGAR2Form 8-K - Current report
18/12/202306:00GLOBEInvivyd Announces Positive Initial Results from Ongoing..
20/11/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202315:10EDGAR2Form 8-K - Current report
09/11/202315:01GLOBEInvivyd Reports Third Quarter 2023 Financial Results and..
02/11/202315:01GLOBEInvivyd to Host Conference Call Discussing Third Quarter..
31/10/202315:01GLOBEInvivyd to Participate in Upcoming Investor Conferences
11/9/202306:10EDGAR2Form 8-K - Current report
11/9/202306:00GLOBEInvivyd Announces Dosing of First Participant in CANOPY..
06/9/202306:00GLOBEInvivyd to Participate in Upcoming Investor Conferences
05/9/202306:05EDGAR2Form 8-K - Current report
05/9/202306:00GLOBEInvivyd Appoints William Duke as Chief Financial Officer
10/8/202315:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:04EDGAR2Form 8-K - Current report
10/8/202315:01GLOBEInvivyd Reports Second Quarter 2023 Financial Results and..
03/8/202315:01GLOBEInvivyd to Host Conference Call Discussing Second Quarter..
27/7/202315:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
IVVD
Invivyd
NEO
JET
Global Crossing Airlines
GATE
MPLXUSDT
Metaplex
LSE
GFRM
NASDAQ
USAT
USA Technologies
COIN
BITTETH
BITTOKEN
NASDAQ
AAZNUXX
Jpmorgan Chase Financial...
NASDAQ
AAYALXX
Bofa Finance Llc Autocal...
NASDAQ
BZ
Kanzhun
USOTC
AKBDY
Akbank Turk Anonim Sirketi (PK)
EU
SGSBZ
Societe Generale 0.75% 2...
LSE
ACM
Accumuli
LSE
14TD
First.abu 25
BIT
UB4Q63
Unicredit Bank
NASDAQ
FMDA
HITB
CVCUSD
Civic
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados